Jim Cramer Compares the Current Selloff in Abbott Labs to the 1999 Market Environment
Key takeaways
- Cramer highlighted it as one of the “greatest American companies,” as he said:
- …Let’s talk about some similarities that have now been popping up, okay?
- Abbott Laboratories (NYSE:ABT) develops and sells healthcare products, including generic medicines, diagnostic systems, nutrition brands, cardiovascular and diabetes care devices, and neuromodulation technologies.
Jim Cramer Compares the Current Selloff in Abbott Labs to the 1999 Market Environment Syeda Seirut Javed Thu, May 14, 2026 at 10:40 PM GMT+7 2 min read ABT Abbott Laboratories (NYSE:ABT) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market. Cramer highlighted it as one of the “greatest American companies,” as he said:
…Let’s talk about some similarities that have now been popping up, okay? In 1999, we saw the wholesale slaughter of all the traditional growth stocks away from tech. It was tough to own any healthcare stock back then. We’re seeing something very similar now. I could give you a long list, but I’d rather just present to you… Abbott Labs, one of the greatest American companies in history. Abbott missed its last quarter by a smidge, and it’s now down 34% for the year. This is Abbott Labs, for heaven’s sake. A market that doles out such harsh punishment for Abbott Labs is a market that despises anything not connected to tech and the data center.
Stock market data. Photo by Jakub Zerdzicki on Pexels